Taipei Exchange - Delayed Quote TWD
GeneReach Biotechnology Corp. (4171.TWO)
18.40
+0.15
+(0.82%)
At close: 1:33:00 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
206,488
206,488
225,460
750,017
1,012,077
Cost of Revenue
88,211
88,211
197,876
259,947
265,097
Gross Profit
118,277
118,277
27,584
490,070
746,980
Operating Expense
254,141
254,141
235,437
249,860
259,570
Operating Income
-135,864
-135,864
-207,853
240,210
487,410
Net Non Operating Interest Income Expense
12,061
12,061
8,710
-4,328
-5,871
Pretax Income
-116,977
-116,977
-218,345
272,371
469,371
Tax Provision
6,703
6,703
-47,993
54,884
98,897
Net Income Common Stockholders
-118,734
-118,734
-166,270
221,337
376,622
Diluted NI Available to Com Stockholders
-118,734
-118,734
-166,270
221,337
376,622
Basic EPS
-2.07
--
-2.89
3.85
6.55
Diluted EPS
-2.07
--
-2.89
3.77
6.45
Basic Average Shares
57,359.42
--
57,532.87
57,458
57,457.50
Diluted Average Shares
57,359.42
--
57,532.87
59,286
58,626.25
Total Expenses
342,352
342,352
433,313
509,807
524,667
Net Income from Continuing & Discontinued Operation
-118,734
-118,734
-166,270
221,337
376,622
Normalized Income
-122,453.20
-122,453.20
-149,548.83
220,432.30
380,615.85
Interest Income
17,995
17,995
14,472
2,285
392
Interest Expense
5,934
5,934
5,762
6,613
6,263
Net Interest Income
12,061
12,061
8,710
-4,328
-5,871
EBIT
-111,043
-111,043
-212,583
278,984
475,634
EBITDA
-36,309
-36,309
-143,695
344,153
535,642
Reconciled Cost of Revenue
88,211
88,211
197,876
259,947
265,097
Reconciled Depreciation
74,734
74,734
68,888
65,169
60,008
Net Income from Continuing Operation Net Minority Interest
-118,734
-118,734
-166,270
221,337
376,622
Total Unusual Items Excluding Goodwill
4,649
4,649
-21,432
1,133
-5,060
Total Unusual Items
4,649
4,649
-21,432
1,133
-5,060
Normalized EBITDA
-40,958
-40,958
-122,263
343,020
540,702
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
929.80
929.80
-4,710.83
228.30
-1,066.15
12/31/2021 - 11/19/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1762.TW Chunghwa Chemical Synthesis & Biotech Co., Ltd.
28.65
+1.96%
6492.TWO Senhwa Biosciences, Inc.
32.25
+1.10%
4168.TWO GlycoNex Incorporation
16.45
+2.17%
6846.TWO Greenyn Biotechnology Co., Ltd
70.50
+0.57%
3176.TWO Medigen Biotechnology Corp.
29.00
+0.35%
4133.TW Abnova (Taiwan) Corporation
27.35
0.00%
3205.TWO Sagittarius Life Science Corp
23.15
-0.22%
4726.TWO Mycenax Biotech Inc.
31.00
+1.47%
1760.TW Panion & Bf Biotech Inc.
67.00
+0.90%
4142.TW Adimmune Corporation
18.40
+1.38%